Pharmaceutical company AbbVie spent $145.7 million last year to promote its drugs through payments to healthcare providers. This includes compensation for consulting, speaking fees, lodging, travel, and meals. The company’s spending on marketing to doctors is the highest since 2017, following the loss of its monopoly on the drug Humira. The payments, disclosed by the Centers for Medicare and Medicaid Services, indicate a more aggressive approach in targeting doctors compared to competitors. AbbVie, known for Humira, is focusing on promoting its products after losing its dominance in the market.
Source link
$145 million in doctor marketing
